Thursday 19 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterprise solutionsVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

Health Canada flags possible capsule mix-up in two Taro candesartan batches

A national, retail-level recall of Taro-Candesartan 8 mg tablets lists Sun Pharma Canada as the firm, with esomeprazole capsules possibly present in the affected packs.

16 Nov 2026 · Health Canada · Regulator

Health Canada has issued a Type II recall for two batches of Taro-Candesartan 8 mg tablets, warning that 20 mg esomeprazole capsules could be present in the product. The notice, updated on 16 November 2026, classes the problem as a product quality issue. It is filed under reference RA-82965.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official record: Health Canada ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →